Insider · CIK 0001263647

TARNOW MICHAEL M

Reports to the SEC for 2 companies · ROCKVILLE, MD

sec.gov

Transactions

Companies

Filings

CIK

0001263647

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-18	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.87	+$7,960.59	71,770
2021-05-18	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,028 sh	$3.67	+$3,772.76	72,798
2021-05-18	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.67	+$18.9K	77,942
2021-05-18	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2021-05-18	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,028 sh	—	—	0
2021-05-18	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2020-10-28	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.76	+$19.3K	74,857
2020-10-28	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.76	+$19.3K	80,001
2020-10-28	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−10.3K sh	—	—	69,713
2020-10-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2020-10-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2020-06-09	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.52	+$18.1K	69,713
2020-06-09	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2020-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-11-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.56	+$18.3K	69,713
2019-11-21	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−5,144 sh	—	—	64,569
2019-11-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.51	+$7,220.07	66,626
2019-11-21	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−2,057 sh	—	—	64,569
2019-11-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2019-11-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2019-09-16	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-05-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.21	+$6,602.97	64,569
2019-05-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2018-12-21	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−5,000 sh	—	—	62,512
2018-06-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.70	+$19K	60,311
2018-06-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,057 sh	$3.66	+$7,528.62	62,368
2018-06-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$3.07	+$15.8K	67,512
2018-06-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2018-06-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,057 sh	—	—	0
2018-06-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2018-06-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-06-19	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,028 sh	$3.51	+$3,608.28	56,195
2017-06-19	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−1,028 sh	—	—	55,167
2017-06-19	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,028 sh	—	—	0
2017-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2017-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2017-01-26	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−7,201 sh	—	—	55,167
2016-12-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.4K sh	$3.21	+$46.2K	69,570
2016-12-12	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−7,202 sh	—	—	62,368
2016-12-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.4K sh	—	—	0
2016-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2016-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,250 sh	—	—	1,250
2016-04-28	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,543 sh	$3.35	+$5,169.05	56,710
2016-04-28	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−1,543 sh	—	—	55,167
2016-04-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,543 sh	—	—	0
2015-11-02	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,041 sh	$5.22	+$26.3K	60,208
2015-11-02	XENEXenon Pharmaceuticals Inc.G Gift	Director	GGift	−5,041 sh	—	—	55,167
2015-11-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,041 sh	—	—	0
2015-06-17	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,543 sh	$4.95	+$7,637.85	55,167
2015-06-17	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,543 sh	—	—	0

Recent filings

Accepted (ET)
May 204
TARNOW MICHAEL M0001209191-21-034400
SEC(opens sec.gov)
Oct 294
TARNOW MICHAEL M0001209191-20-056229
SEC(opens sec.gov)
Jun 104
TARNOW MICHAEL M0001209191-20-035608
SEC(opens sec.gov)
Jun 24
TARNOW MICHAEL M0001209191-20-033643
SEC(opens sec.gov)
Nov 224
TARNOW MICHAEL M0001209191-19-057754
SEC(opens sec.gov)

Companies

Address

ENTREMED, INC. 9640 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850